Cargando…

Why Do People Die of Anaphylaxis?—A Clinical Review

Anaphylaxis is a source of anxiety for patients and healthcare providers. It is a medical emergency that presents with a broad array of symptoms and signs, many of which can be deceptively similar to other diseases such as myocardial infarction, asthma, or panic attacks. In addition to these diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Arvind, Teuber, Suzanne S., Gershwin, M. Eric
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270738/
https://www.ncbi.nlm.nih.gov/pubmed/16584114
http://dx.doi.org/10.1080/17402520500376277
_version_ 1782151751133036544
author Kumar, Arvind
Teuber, Suzanne S.
Gershwin, M. Eric
author_facet Kumar, Arvind
Teuber, Suzanne S.
Gershwin, M. Eric
author_sort Kumar, Arvind
collection PubMed
description Anaphylaxis is a source of anxiety for patients and healthcare providers. It is a medical emergency that presents with a broad array of symptoms and signs, many of which can be deceptively similar to other diseases such as myocardial infarction, asthma, or panic attacks. In addition to these diagnostic challenges, anaphylaxis presents management difficulties due to rapid onset and progression, lack of appropriate self-treatment education and implementation by patients, severity of the allergic response, exacerbating medications or concurrent disease, and unpredictability. The most common causes of anaphylaxis are food allergies, stinging insects and immunotherapy (allergy shots) but idiopathic anaphylaxis, latex allergy and drug hypersensitive all contribute to the epidemiology. Reactions to IVP and other dyes are coined anaphylactoid reactions but have identical pathophysiology and treatment, once the mast cell has been degranulated. As many antigens can be the trigger for fatal anaphylaxis, it is useful to examine the features of each etiology individually, highlighting factors common to all fatal anaphylaxis and some specific to certain etiologies. Generally what distinguishes a fatal from non fatal reaction is often just the rapidity to apply correct therapy. Prevention is clearly the key and should identify high-risk patients in an attempt to minimize the likely of a severe reaction. Although fatal anaphylaxis is rare, it is likely underreported.
format Text
id pubmed-2270738
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-22707382008-03-31 Why Do People Die of Anaphylaxis?—A Clinical Review Kumar, Arvind Teuber, Suzanne S. Gershwin, M. Eric Clin Dev Immunol Research Article Anaphylaxis is a source of anxiety for patients and healthcare providers. It is a medical emergency that presents with a broad array of symptoms and signs, many of which can be deceptively similar to other diseases such as myocardial infarction, asthma, or panic attacks. In addition to these diagnostic challenges, anaphylaxis presents management difficulties due to rapid onset and progression, lack of appropriate self-treatment education and implementation by patients, severity of the allergic response, exacerbating medications or concurrent disease, and unpredictability. The most common causes of anaphylaxis are food allergies, stinging insects and immunotherapy (allergy shots) but idiopathic anaphylaxis, latex allergy and drug hypersensitive all contribute to the epidemiology. Reactions to IVP and other dyes are coined anaphylactoid reactions but have identical pathophysiology and treatment, once the mast cell has been degranulated. As many antigens can be the trigger for fatal anaphylaxis, it is useful to examine the features of each etiology individually, highlighting factors common to all fatal anaphylaxis and some specific to certain etiologies. Generally what distinguishes a fatal from non fatal reaction is often just the rapidity to apply correct therapy. Prevention is clearly the key and should identify high-risk patients in an attempt to minimize the likely of a severe reaction. Although fatal anaphylaxis is rare, it is likely underreported. Hindawi Publishing Corporation 2005-12 /pmc/articles/PMC2270738/ /pubmed/16584114 http://dx.doi.org/10.1080/17402520500376277 Text en Copyright © 2005 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kumar, Arvind
Teuber, Suzanne S.
Gershwin, M. Eric
Why Do People Die of Anaphylaxis?—A Clinical Review
title Why Do People Die of Anaphylaxis?—A Clinical Review
title_full Why Do People Die of Anaphylaxis?—A Clinical Review
title_fullStr Why Do People Die of Anaphylaxis?—A Clinical Review
title_full_unstemmed Why Do People Die of Anaphylaxis?—A Clinical Review
title_short Why Do People Die of Anaphylaxis?—A Clinical Review
title_sort why do people die of anaphylaxis?—a clinical review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270738/
https://www.ncbi.nlm.nih.gov/pubmed/16584114
http://dx.doi.org/10.1080/17402520500376277
work_keys_str_mv AT kumararvind whydopeopledieofanaphylaxisaclinicalreview
AT teubersuzannes whydopeopledieofanaphylaxisaclinicalreview
AT gershwinmeric whydopeopledieofanaphylaxisaclinicalreview